By Hideyuki Sano
TOKYO, May 21 (Reuters) - Japan's Nikkei share average
snapped a four-day winning streak on Thursday, as investors were
reluctant to chase markets after the benchmark hit a 2-1/2-month
high, raising concerns that stocks were potentially overvalued.
The Nikkei share average .N225 closed 0.21% lower at
20,552.31. Earlier in the session, the index rose to as high as
20,734.91, its strongest level since March 6. The broader Topix
.TOPX lost 0.23% to 1,491.21.
Although the market has rallied on hopes of a quick economic
recovery following countries' move to ease coronavirus
restrictions, investors have noted the market's valuations are
getting stretched.
The Nikkei has rallied 8.6% so far this quarter after
suffering a 20% loss in the previous quarter on worries about
severe economic damages from the COVID-19 pandemic.
The Topix is traded at 14 times its expected earnings,
sharply higher than the trough of 10.6 touched in March and near
last year's peak of 14.4.
The turnover of the Tokyo Stock Exchange's main board has
fallen below 2 trillion yen to the lowest level in almost a
month, another sign of a lack in strong convictions among
investors to chase the market higher.
The Japanese government is expected to lift its state of
emergency later in the day in three prefectures around Osaka,
the country's second-biggest urban area after Tokyo, and might
take similar steps for Tokyo by the end of month. As more people are expected to work from home even after the
end of emergency, railway companies are expected to lose revenue
from commuting and business travels, while cosmetic companies
are bracing for a drop in sales.
Railway operator Tokyu Corp 9005.T , Keio 9008.T , East
Japan Railway 9020.T all lost about 2.4% each, while Central
Japan Railway 9020.T shed 1.6%.
Cosmetic maker Shiseido 4911.T slumps 1.8%.
"Trading on winners and losers from the coronavirus will be
our main course of actions," said Hisashi Iwama, fund manager at
Asset Management One.
"Even though some shares now look bubbly, this polarisation
could continue further for the time being.
On the other side of the spectrum, I'rom Group 2372.T rose
21.1% by the daily limit after the bio-tech firm said its
coronavirus vaccine development project won a backing from a
public research body.
The index of Mothers .MTHR , a start-up market in the Tokyo
Stock Exchange, climbed 1.9% to a one-year high, with Anges
4563.T , which is also seeking to develop a coronavirus
vaccine, rising 12%.
Elsewhere, Taiheiyo Cement 5233.T gained 12.8% and Sompo
Holdings 8630.T rose 7.1% following their share buyback
announcements.